Abstract
Medical records of 51 patients with a diagnosis of pars planitis (97 eyes) were reviewed. Based upon the severity of vitreous inflammation, in 34 eyes (35) the condition was classified as mild, in 38 (39) as moderate, and in 25 eyes (26) as severe. Vascular sheathing was present in 51 eyes (53), snowballs in 42 (43), snowbanks in 29 (30), cataract in 19 (20), cystoid macular edema in 26 (27), retinal detachment in 4 (4) and glaucoma in 3 (3) eyes. Treatment consisted of prednisone and periocular injections of deposteroids or immunosuppressive agents; 13 patients required surgery for retinal repair, glaucoma, vitreous opacities or cataract. After treatment the visual acuity improved in 58 of the eyes, did not change in 33, and worsened in 9.
Similar content being viewed by others
References
Henderly DE, Genstler AJ, Rao NA, Smith RE. Pars planitis. Trans Ophthalmol Soc U.K. 1986; 105: 227–32.
Schepens CL. L'inflammation de la region de l'ora serrata et ses sequelles. Bull Soc Franc Ophthalmol 1959; 73: 113–24.
Welch RB, Maumenee AE, Wahlen HE. Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole. Arch Ophthalmol 1960; 64: 540–9.
Dinning WJ. Intermediate uveitis: History, terminology, definition. Pars planitis: systemic disease associations. Dev Ophthalmol 1992; 23: 3–8.
Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993; 100: 818–25.
Forster DJ, Rao NA, Smith RE. Corticosteroids in the treatment of intermediate uveitis. Dev Ophthalmol 1992; 23: 163–70.
Althaus C, Sundmacher R. Intermediate uveitis. Epidemiology, age and sex distribution. Dev Ophthalmol 1992; 23: 9–14.
Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol 1987; 103: 131–6.
Eichenbaum JW, Friedman AH, Mamelok AE. A clinical and histopathological review of intermediate uveitis (‘pars planitis’). Bull NY Acad Med 1988; 64: 164–74.
Henderly DE, Haymond RS, Rao NA, Smith RE. The significance of the pars plana exudate in pars planitis. Am J Ophthalzmol 1987; 103: 669–71.
Wetzig RP, Chan CC, Nussenblatt RB, Palestine AG, Mazur DO, Mittal KK. Clinical and immunopathological studies of pars planitis in a family. Br J Ophthalmol 1988; 72: 5–10.
Malinowski SM, Pulido JS, Goeken NE, Brown CK, Folk JC. The association of HLA-B8, B51, DR2 and multiple sclerosis in pars planitis. Ophthalmology 1993; 100: 1199–1205.
Graham EM, Edelsten C. Intermediate uveitis and sarcoidosis. Dev Ophthalmol 1992; 23: 106–10.
Smith RE, Godfrey WA, Kimura SJ. Chronic cyclitis. I. Course and visual prognosis. Trans Am Acad Ophthalmol Otolaryngol 1973; 77: 760–8.
Kimura SJ, Hogan MJ. Chronic cyclitis. Arch Ophthalmol 1964; 71: 193–201.
Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc UK 1976; 96: 151–7.
Pruett RC, Brockhurst RJ, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol 1974; 77: 448–53.
Schmidt F. Fluorescein angiography in intermediate uveitis. Dev Ophthalmol 1992; 23: 139–44.
Godfrey WA, Smith RE, Kimura SJ. Chronic cyclitis. Corticos-teriod therapy. Trans Am Ophthalmol Soc 1976; 74: 178–88.
Smith RE, Nozik RA. Uveitis: A clinical approach to diagnosis and managment. 2nd ed. Baltimore, Pa, Williams & Wilkins, 1989:63–8.
Rao NA, Forster DJ, Augsburger JJ. The Uvea: Uveitis and intraocular neoplasms. New York, NY, Gower, 1992; 6.1–6.4.
Kaufman AH, Foster CS. Cataract extraction in patients with pars planitis. Ophthalmology 1993; 100: 1210–7.
Nölle B, Eckardt C. Cellular phenotype of vitreous cells in intermediate uveitis. Dev Ophthalmol 1992; 23: 145–9.
Nussenblatt RB, Palestine AG. Ciclosporin (Sandimmum) therapy. Experience in the treatment of pars planitis and present therapeutic guidelines. Dev Ophthalmol 1992; 23: 177–84.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ortega-Larrocea, G., Arellanes-Garcia, L. Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico city. Int Ophthalmol 19, 117–120 (1995). https://doi.org/10.1007/BF00133182
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00133182